The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMWG.L Regulatory News (MWG)

  • There is currently no data for MWG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Increase in Orders for Reagent Consumables

30 Mar 2020 07:00

RNS Number : 9531H
Modern Water PLC
30 March 2020
 

AIM share code: MWG

30 March 2020

 

Modern Water PLC

 

("Modern Water" or "Company")

 

UK bacteria production to detect water contamination begins amid COVID-19 public health crisis

 

Orders of water contamination detection consumables up 46% in Q1 2020 compared to Q1 2019

 

Modern Water announces that orders for water contamination detection bacteria consumables have increased by 46% in Q1 2020 compared to Q1 2019. Two months of stock have been shipped in the last two weeks amid growing demand, believed to be connected to the global COVID 19 public health crisis, from existing customers across Spain, Italy and China. Production by Integumen plc, of Modern Water's monitoring bacteria reagent has begun at the University of York, UK, 6 weeks ahead of the originally planned production date.

 

Simon Humphrey, CEO of Modern Water, commented:

"In the last two months we have been able to adapt quickly to our revenue sharing business model which will now give us access to higher volumes on two continents. With production laboratories in Delaware, US and our partner Integumen's production facilities coming on stream in York, UK, we have removed the continuity of supply risk for our customers. This puts Modern Water in a strong position to address the increased demand in a shorter time period, assuring clients as we reduce the order backlog and meet their growing need for our water monitoring products and services."

 

Regulatory requirements

Below are countries in which Modern Water Microtox Acute Reagent is an approved product to be used in order to make decisions on the safety of drinking water and wastewater effluent.

 

· Canada, Alberta Energy Regulator, Directive 050: Drilling Waste Management (August 2019)

· Mexico, Mexican Standard NMX-AA-112SCFI-2017: Water and Sediment Analysis - Acute Toxicity Evaluation with Vibrio fischeri - Test Method

· Spain, International Standard Organization, ISO 11348-3: Water quality - Determination of the inhibitory effect of water samples on the light emission of Vibrio fischeri (Luminescent bacteria test) Part 3: Method using freeze- dried bacteria

· Italy, International Standard Organization, ISO 11348-3: Water quality - Determination of the inhibitory effect of water samples on the light emission of Vibrio fischeri (Luminescent bacteria test) Part 3: Method using freeze- dried bacteria

· Taiwan, Environmental Protection Agency, NIEA B301.10C: Determination of the acute toxicity - luminescent bacteria test

· United States, large municipalities rely on Microtox Acute Reagent for water quality testing such as drinking water effluent, including but not limited to Fairfax Water (Fairfax, VA) and LA Dept of Water (Los Angeles, CA).

 

 

Modern Water plc

Simon Humphrey, CEO

 

+44 (0)20 3827 3439

Cairn Financial Advisers LLP (Nominated Adviser)

 

Sandy Jamieson

Liam Murray

Ludovico Lazzaretti

+44 (0)20 7213 0880

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker / Zoe Alexander

+44 (0) 20 3621 4120

 

About Modern Water

Modern Water was established in 2006 to develop and commercialise water recovery technologies to counter water crisis problems arising from climate change and a growing global population. Having invested £20m over the last 14 years, the results comprise of a robust patent portfolio of cutting edge technology, focused on monitoring of contaminated water and decontamination of wastewater, making recycling of water more efficient. Six countries across the world have legislated that Modern Water monitoring test systems are written into their environmental protection legislation.

 

About Integumen plc

Integumen is a scientific research and AI-as-a-Service company focused on production and analysis of bacteria, virus and toxins utilising artificial intelligent data analytics in regulatory technology, from scientifically proving the impact of skincare product claims on skin microbiome for top 10 global cosmetic company clients to remotely detecting water contamination in real-time.

 

About University of York

The University of York is a collegiate research university, located in the city of York, England. Established in 1963, the university has expanded to more than thirty departments and centres. With over £8 million of capital equipment, 2,000 square meters of laboratories, the purpose-built centre of excellence provides access to state-of-the-art bioscience technologies for external academic laboratories and commercial business users. It has all the relevant equipment needed to begin production of the water contamination detection bacteria immediately.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCPPUQPWUPUGWB
Date   Source Headline
3rd Sep 20199:00 amRNSPrice Monitoring Extension
3rd Sep 20197:00 amRNSPlacing & Total Voting Rights
30th Aug 20194:08 pmRNSUpdate re Restructuring
23rd Aug 20192:45 pmRNSBoard Changes
6th Aug 20194:11 pmRNSRe-structuring
23rd Jul 20191:27 pmRNSUpdate Re: Membrane Division
10th Jul 20193:31 pmRNSFurther re: Working capital update
7th Jun 201910:55 amRNSTrading Update
22nd May 20193:30 pmRNSResult of AGM
1st May 20197:00 amRNSDirector/PDMR Shareholding
18th Apr 20196:19 pmRNSFinal Results
29th Mar 20192:27 pmRNSUpdate re Announcement of Results
27th Mar 20197:00 amRNSGibraltar Planning Office OKs Treatment Plant
13th Mar 201911:28 amRNSSale of Brine Concentration Plant
7th Mar 20197:00 amRNSAppointment of Nominated Adviser
28th Feb 20197:00 amRNSTrading Update for the Year Ended 31 December 2018
8th Feb 20197:00 amRNSPlanning Application Submitted
1st Feb 20197:00 amRNSIssue of Shares
31st Jan 20197:00 amRNSAppointment of Joint Broker
29th Jan 201912:14 pmRNSMajor Product Upgrade
21st Jan 20197:00 amRNSEquity Issue & Result of Placing
14th Dec 20189:45 amRNSSale of AquaPak Desalination Plant
29th Oct 20189:48 amRNSResult of Open Offer
24th Oct 201811:31 amRNSDirector/PDMR Shareholding and Open Offer Update
18th Oct 20187:00 amRNSModern Water Signs AMBC Collaboration for Africa
11th Oct 20187:00 amRNSLaunch of Open Offer
27th Sep 20187:00 amRNSTechnology Partnership in China Deepens
20th Sep 20187:00 amRNSInterim Results
5th Sep 201810:49 amRNSInterim Results Date
21st Aug 20187:00 amRNSReceipt of Chinese Investment
2nd Aug 20187:00 amRNSTrading Statement
6th Jul 20182:45 pmRNSHolding(s) in Company
5th Jul 20184:40 pmRNSSecond Price Monitoring Extn
5th Jul 20184:35 pmRNSPrice Monitoring Extension
5th Jul 20187:15 amRNSChinese Joint Venture and Equity Issue
4th Jul 20187:00 amRNSBrine Treatment Plant Opened
10th May 20182:13 pmRNSDirector Disclosure
3rd May 201812:44 pmRNSDirector/PDMR Shareholding
25th Apr 201812:08 pmRNSResult of AGM
25th Apr 20187:00 amRNSAGM Statement
4th Apr 20187:00 amRNSHolding(s) in Company
29th Mar 20187:00 amRNSNew Finance Facility
29th Mar 20187:00 amRNSFinal Results
21st Mar 201811:46 amRNSResults for the Year Ended 31 December 2017
31st Jan 20182:56 pmRNSHolding(s) in Company
30th Jan 201810:00 amRNSProgress on Gibraltar Wastewater Treatment Plant
14th Dec 20177:00 amRNSAppointment of Non-Executive Director
8th Nov 20177:00 amRNSSale of Brine Concentration Technology in China
13th Sep 20177:00 amRNSHalf-year Report
6th Jul 201710:13 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.